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O B J E C T I V E S We sought to assess the correlation between mitral valve characteristics and severity
of mitral regurgitation (MR) in subjects with mitral valve prolapse (MVP) undergoing cardiac magnetic
resonance (CMR) imaging.
B A C KG ROUND Compared with extensive echocardiographic studies, CMR predictors of MVP-
related MR are unknown. The severity of MR at the time of diagnosis has prognostic implication for
patients; therefore, the identiﬁcation of determinants of MR and its progression may be important for
risk stratiﬁcation, follow-up recommendations, and surgical decision making.
METHOD S Seventy-one MVP patients (age 54  11 years, 58% males, left ventricular [LV] ejection
fraction 65  5%) underwent cine CMR to assess annular dimensions, maximum systolic anterior and
posterior leaﬂet displacement, papillary muscle (PM) distance to coaptation point and prolapsed leaﬂets,
as well as diastolic anterior and posterior leaﬂet thickness and length, and LV volumes and mass.
Velocity-encoded CMR was used to obtain aortic outﬂow and to quantify MR volume.
R E S U L T S Using multiple linear regression analysis including all variables, LV mass (p  0.001),
anterior leaﬂet length (p  0.006), and posterior displacement (p  0.01) were the best determinants of
MR volume with a model-adjusted R2  0.6. When the analysis was restricted to valvular characteristics,
MR volume correlated with anterior mitral leaﬂet length (p 0.001), posterior mitral leaﬂet displacement
(p  0.003), posterior leaﬂet thickness (p  0.008), and the presence of ﬂail (p  0.005) with a
model-adjusted R2  0.5. We also demonstrated acceptable intraobserver and interobserver variability
in these measurements.
CONC L U S I O N S Anterior leaﬂet length, posterior leaﬂet displacement, posterior leaﬂet thickness,
and the presence of ﬂail are the best CMR valvular determinants of MVP-related MR. The acceptable
intraobserver and interobserver variability of our measurements conﬁrms the role of CMR as an imaging
modality for assessment of MVP patients with signiﬁcant MR. (J Am Coll Cardiol Img 2010;3:1037–45)
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1038itral valve prolapse (MVP) is a common
disorder afflicting 2% to 3% of the
general population (1). Typical myxo-
matous changes in the mitral leaflet
issue cause superior displacement of the leaflets
nto the left atrium (1,2). MVP can be associated
ith significant mitral regurgitation (MR), arrhyth-
ias, bacterial endocarditis, thrombotic events,
ongestive heart failure, and even sudden cardiac
eath (3–5).
See page 1046
Controversy exists regarding the prognosis of
VP (1,6 – 8). These discrepancies may be due to
election bias in the referral of either tertiary care,
ymptomatic patients or, conversely, healthier
symptomatic volunteers (8). Changes in diag-
ostic criteria may have further exacerbated these
ontroversies (9). More recently, a community-
ased study carried out in a primary care hospi-
tal has underscored the heterogeneity of
MVP, and its wide prognostic spectrum
(3). The common denominator of these
and other prognostic studies is the role
of MR at diagnosis in determining the
risk for cardiovascular morbidity and
mortality (6 – 8,10 –13).
Given the prognostic implications of
MR, identification of determinants of
progression is important for risk stratifica-
tion, follow-up recommendations and sur-
ical decision making. Echocardiographic studies
ave analyzed determinants of MVP-related MR
nd its progression (12–14). Among these determi-
ants, leaflet thickness, progression of the valvular
esion, particularly a new flail leaflet, and an increase
n the mitral annular diameter were the most
mportant predictors of MR (12).
Cardiac magnetic resonance (CMR) is an impor-
ant noninvasive imaging modality that readily
dentifies MVP (15). In addition, CMR can quan-
ify MR using phase-contrast velocity mapping
16,17). Because CMR can reliably provide quan-
itative determination of ventricular volumes and
unction (18,19), it is becoming an important clin-
cal tool for follow-up of patients with MVP and
oderate-to-severe MR in anticipation of future
itral valve repair (20).
Compared with echocardiography, CMR predic-
ors of MVP-related MR are yet to be defined. We
ought to investigate the correlation between mitral
ralve characteristics and MR in the MVP popula- sion, so as to further define the potential role of
MR in this common disease.
E T H O D S
atient selection. Seventy-five subjects with echo-
ardiographically identified MVP without greater
han mild aortic regurgitation were prospectively
nrolled based on an institutional review board–
pproved protocol. Similar to echocardiography
9,21), CMR evidence of MVP was defined as
2-mm displacement of the mitral leaflets into the
eft atrium as viewed in the left ventricular (LV)
utflow tract orientation (15). Of the 75 subjects, 4
5%) were excluded due to suboptimal CMR image
uality, resulting in a final cohort of 71 participants
age 55 11 years, 58% males). All subjects were in
ormal sinus rhythm without any history of coro-
ary artery disease or intrinsic cardiomyopathies.
MR. CMR imaging was performed using a Philips
chieva 1.5-T whole-body CMR scanner (Philips
edical Systems, Best, the Netherlands) equipped
ith a 5-element cardiac coil. Breath-hold, retro-
pectively electrocardiogram-gated cine, steady-
tate free-precession images were acquired in the 2-
nd 4-chamber long-axis views, and a short-axis stack
overing the entire LV (8-mm slices with 2-mm
aps). The LV outflow track long-axis stack images
Fig. 1) were obtained by prescribing an image plane
erpendicular to the mitral annular major axis cen-
ered at the aortic outflow track (15). Six to eight
-mm slices with no gap were obtained to cover the
ntire mitral valve. Sequence parameters were repeti-
ion time 3 ms, echo time 1.5 ms, flip angle 60°,
eld-of-view 320  320 mm2, matrix 160  160.
emporal resolution was 30 to 35 ms. A free-
reathing, electrocardiogram-triggered, phase-
ontrast velocity-encoded CMR sequence of the aor-
ic outflow was acquired in the axial plane at the level
f the bifurcation of the pulmonary artery, as previ-
usly described (17).
mage analysis. The CMR images were analyzed
sing ViewForum (Release 4) software (Philips
edical Systems) as previously described (15).
riefly, in the LV outflow track view (Fig. 1A),
nterior and posterior leaflet displacement were
easured as the maximum excursion of the leaflets
uring systole (each phase repeatedly examined to
nd the maximum excursion) beyond the mitral
nnular diameter as defined by a line connecting the
nferolateral mitral annulus to the aortomitral junc-
ion (Fig. 1A). Additional measurements on theB B R E V I A T I O N S
N D A C R O N YM S
MR cardiac magnetic
esonance
V left ventricle/ventricula
Rmitral regurgitation
VPmitral valve prolapseame image included the distance between the
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1039apillary muscle (PM) and the mitral leaflet coap-
ation point and the anterior and posterior pro-
apsed leaflets, respectively (Fig. 1B). In the same
iew, we measured anterior and posterior leaflet
hickness and length in diastole (Figs. 1C and 1D)
each phase repeatedly examined for the most in-
lane view). The annulus was measured at end-
ystole in the 2- and 4-chamber views. LV
imensions were measured in the short-axis view
t the level of the chordae. LV volumes were
easured by tracing the end-diastolic and
systolic LV endocardial contours in each slice
nd applying a summation of discs method. The
V ejection fraction was calculated as: (LV end-
iastolic volume  LV end-systolic volume)/LV
nd-diastolic volume. LV mass was measured by
racing endocardial and epicardial contours in-
luding the PMs in the ventricular volumes. The
R volume was calculated as the difference
etween LV stroke volume and the forward aortic
ow volume. The MR fraction was obtained by
ividing MR volume by the LV stroke volume. MR
Figure 1. Cine CMR LV Outﬂow View
(Top panels) Systolic measurements of (A) anterior leaﬂet displacem
diameter (MAD); and (B) papillary muscle (PM) distance to anterior
(PMC). (Bottom panels [zoomed in]): diastolic measurements of (C)
rior leaﬂet thickness (AT), posterior leaﬂet thickness (PT).ategories were graded as: 0 (none to trace) (0% to t%); 1 (mild) (5% to 16%); 2 (moderate) (6% to
5%); 3 (moderate to severe) (26% to 48%); and
 (severe) (48%) (17).
tatistical methods. Subject characteristics are pre-
ented as means with standard deviations for con-
inuous traits and as frequency and percentage for
ategorical traits. The relationship between subject
haracteristics (age, gender, body surface area, LV
ass, number of prolapsed leaflets, presence of flail
eaflet) and mitral valve measurements (annular
imensions, leaflet displacement, thickness, and
ength, and PM distance to coaptation point and
rolapsed leaflets) with the outcome (MR volume)
as assessed using univariate linear regression with
significance level of 0.05.
Because MR volume calculations are derived
rom LV volumes, the LV volumes were not in-
luded in the models to investigate MR determi-
ants. A multiple linear regression model was first
erformed with stepwise regression (forward and
ackward selection) and included all the afore-
entioned univariate variables, and interaction
(AD), posterior leaﬂet displacement (PD), and mitral annular
et (PMA), to posterior leaﬂet (PMP), and to coaptation point
rior leaﬂet length (AL), posterior leaﬂet length (PL), and (D) ante-ent
leaﬂ
anteerms for variables with high correlation (correla-
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1040ion coefficient 0.7). The resulting model in-
luded variables appearing in both forward and
ackward selection, as these variables had the most
ignificant effects on MR volume. Recognizing the
umber of variables was large with respect to the
ample size (overfitting), we further performed
ultiple linear regression, focusing only on valvular
haracteristics (the presence of flail, anterior and
osterior length, thickness, and displacement). Re-
idual plots were examined for a relationship be-
ween residual and predicted values. Shapiro-Wilk
est was employed to test the normality of residuals
or the overall and the valvular model. Receiver
perating curve analysis was performed to deter-
ine the best cutoff for severe (3 and 4) MR for
alvular determinants when appropriate.
Two independent observers performed measure-
ents of annular dimension, leaflet displacement,
M distance to coaptation point and prolapsed
eaflets in systole, and leaflet length and thickness in
iastole in 30 randomly selected subjects separated
y at least 5 days to assess intraobserver and
nterobserver variability. Intraobserver variability
as calculated as the average of the percentage
ifference between the same observer’s 2 measure-
ents divided by the mean of the 2 measurements
er subject. Interobserver variability was calculated
y the average of percentage difference of the 2
bservers’ measurements over their mean measure-
ents per subject. Bland-Altman graphs were plot-
Table 1. Patient Characteristics
MVP (n  71)
Age, yrs 55  11
Male 41 (58%)
BSA, m2 1.8  0.2
LVEF, % 65  5
MR
0 2 (3%)
1 5 (7%)
2 13 (18%)
3 39 (55%)
4 12 (17%)
Presence of ﬂail leaﬂet 15 (21%)
Number of prolapsed leaﬂets
Bileaﬂet 37 (52%)
Posterior 34 (48%)
Anterior 0 (0%)
Values are mean  SD or n (%).
BSA  body surface area; LVEF  left ventricular ejection fraction; MR 
mitral regurgitation; MVP  mitral valve prolapse.ed for the significant determinants for MR.All statistical analyses were performed with
TATA version 10 (StataCorp, College Station,
exas) and SAS version 9.2 (SAS Institute, Cary,
orth Carolina).
E S U L T S
ubject characteristics and CMR ﬁndings. The clinical
haracteristics and CMR parameters of the study
ubjects are summarized in Tables 1 and 2. The
ubjects were mostly middle aged with average body
urface area and preserved LV ejection fraction.
ifty-one (72%) subjects had greater or equal to 3
moderate to severe) MR. Fifteen subjects (21%)
ad a flail leaflet on echocardiography, of which 12
80%) were initially identified on CMR by 1 ob-
erver blinded to echocardiography results. The
resence of flail in the remaining 3 patients was
dentified by consensus review of 2 observers.
eterminants of MR. By univariate regression anal-
sis, MR volume correlated with annular dimen-
Table 2. CMR Parameters
MVP (n  71)
LVEDD, mm 59 6
LVEDDI, mm/m2 32 4
LVESD, mm 37 5
LVEDV, ml 193 48
LVEDVI, ml/m2 104 21
LVESV, ml 68 19
LV mass, g 118 37
LVMI, g 63 17
MAD, mm
2-chamber 45 6
3-chamber 40 6
4-chamber 44 6
AD, mm 2.8 2.9
AL, mm 26 5
AT, mm 2.7 0.6
PD, mm 6.9 3
PL, mm 17 4
PT, mm 2.8 0.5
PMC, mm 28 7
PMA, mm 33 7
PMP, mm 35 8
Values are mean  SD.
AD  anterior leaﬂet displacement; AL  anterior leaﬂet length; AT 
anterior leaﬂet thickness; LV  left ventricular; LVEDD  left ventricular
end-diastolic diameter; LVEDDI  left ventricular end-diastolic diameter
indexed to body surface area; LVEDV  left ventricular end-diastolic volume;
LVEDVI  left ventricular end-diastolic volume indexed to body surface area;
LVESD  left ventricular end-systolic diameter; LVESV  left ventricular
end-systolic volume; LVMI  left ventricular mass indexed to body surface
area; MAD  mitral annular diameter; MVP  mitral valve prolapse; PD 
posterior leaﬂet displacement; PL  posterior leaﬂet length; PMA  papillary
muscle distance to anterior leaﬂet; PMC  papillary muscle distance to
coaptation point; PMP  papillary muscle distance to posterior leaﬂet; PT 
posterior leaﬂet thickness.
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1041ions, posterior leaflet displacement, PM distance
o coaptation point and prolapsed leaflets, the
resence of flail, anterior and posterior leaflet thick-
ess, LV diameters, LV mass, male sex, and body
urface area (Table 3). The anterior leaflet displace-
ent variable was positively skewed due to the “0”
alues assigned to the patients with posterior-only
rolapse. In bileaflet subjects, anterior leaflet dis-
lacement was significantly correlated with MR
olume (p  0.017).
In the overall stepwise regression model, posterior
eaflet displacement, anterior leaflet length, and LV
ass remained significant in both forward and back-
ard selections (p  0.01, p  0.006, and 0.001,
espectively, model-adjusted R2  0.6). When we
erformed stepwise regression on valvular characteris-
ics only, forward and backward selections yielded the
ame significant predictors: anterior leaflet length,
osterior displacement, posterior thickness, and the
resence of flail (p  0.001, p  0.003, p  0.008,
nd p  0.005, respectively, with model-adjusted R2
0.5) (Table 3). Residual plots showed a linear
elationship between residual and predicted values.
hapiro-Wilk test showed normality of residuals for
he overall model with a p value of 0.3857 and the
alvular model with a p value of 0.4325.
Tertiles of anterior leaflet length in relationship
o MR (Fig. 2) showed proportional increase with
he amount of MR. Receiver operating curve anal-
sis was performed on posterior leaflet thickness
nd displacement to determine the best cutoff for
evere (3 and 4) MR. A thickness of 2.5 mm
nd a displacement of 6 mm had the most area
nder the curve (0.76 and 0.80, respectively). Sig-
ificant differences in MR are shown using these
utoffs in Figure 2.
eproducibility of measurements. The mean per-
entage intraobserver and interobserver variabilities
re shown in Table 4 for each valvular parameter.
ow intraobserver variability (10%) can be
chieved with all parameters. Bland-Altman in-
raobserver and interobserver variability plots are
hown in Figure 3 for posterior leaflet displacement,
nterior leaflet length, and posterior leaflet thick-
ess. The average intraobserver and interobserver
iases are small. The variabilities are consistent
cross average values of the parameters.
I S C U S S I O N
n this CMR study of 71 subjects with MVP and
R, we found that anterior leaflet length, posterioreaflet displacement, posterior leaflet thickness, and vhe presence of flail are the best CMR valve
eterminants of MVP-related MR.
Surgical intervention for chronic mitral regurgi-
ation in asymptomatic individuals is recommended
n the basis of regurgitation severity and hemody-
amic consequences on the LV (22). Echocardiog-
aphy is commonly used to closely follow patients with
hronic MR. Regurgitation volume and fraction can
e determined both quantitatively and semiquantita-
ively (23). However, limitations exist with echocar-
iography due to poor image quality, significant vari-
bility in flow diameter measurements, and geometric
ssumptions of flow orifice (23).
CMR imaging is a flexible, noninvasive modality
hat provides the gold-standard measurement of LV
olumes and function. In addition, phase-contrast
MR can easily quantify aortic and pulmonic flow
elocities and volumes. These data can be combined
ith LV or right ventricular volumetric data to deter-
ine atrioventricular regurgitant volume and fraction
16,17,20). When properly acquired with correction of
ackground eddy currents and concomitant gradients,
hase-contrast velocity mapping can provide the most
ccurate indirect measurement of MR (24,25). Re-
ently, CMR criteria for MVP diagnosis have been
stablished based on a comparison with echocardiog-
aphy (15). With properly prescribed imaging planes,
ine CMR is able to visualize all parts of the mitral
Table 3. Correlation of Patient Characteristics and CMR Parame
MR Volume
Univariate
Regression
(p Value)
Overall Stepwise
Regression
(p Value)
V
Male sex 0.001
Body surface area 0.004
Age 0.90
LV mass 0.001 0.001
MAD
2-chamber 0.001
3-chamber 0.001
4-chamber 0.002
Flail 0.002
AD 0.30
AL 0.001 0.006
AT 0.02
PD 0.001 0.01
PL 0.001
PT 0.001
PMC 0.001
PMA 0.001
PMP 0.001
CMR  cardiac magnetic resonance; MR  mitral regurgitation; other abbreviaters With
alvular Stepwise
Regression
(p Value)
—
—
—
—
—
—
—
—
0.005
0.001
0.003
0.008
—
—
—alve apparatus throughout the entire cardiac cycle
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104215). In an era when interventions for mitral valve
isease improve and are recommended earlier in the
isease course (22), it becomes particularly important
o assess MVP patients with a precise and accurate
odality such as CMR.
Diffuse leaflet thickening, elongation, and redun-
ancy are the classic echocardiographic features of
rver and Interobserver Variability
% Variability
(Intraobserver 1)
% Variability
(Intraobserver 2)
% Variability
(Interobserver)
3 4 5 5 6 4
8 14 8 10 15 17
8 9 12 10 13 9
10 11 17 13 12 11
8 11 16 15 24 15
7 8 14 12 24 15
9 10 22 14 14 13
6 6 13 12 17 15
7 8 6 7 13 13
5 5 11 9 12 11
.
A
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Figure 2. Relationship of MR With Mitral Valve Parameters
The bar graphs show mitral regurgitation (MR) volume according t
ment using 6 mm as the cutoff, (C) posterior leaﬂet thickness using
differences between groups, and p  0.05 was considered signiﬁcasble 2.yxomatous leaflets associated with significant MR
equiring valvular surgery, ventricular arrhythmia,
nd sudden death (26–29). Compared with echocar-
iography, CMR predictors of MVP-related MR
ave not been reported. A prior echocardiographic
tudy has shown that MVP patients have increased
nterior and posterior leaflet lengths compared with
ontrols, and both leaflet lengths were increased in
VP patients with MR, as compared with patients
ith no MR (30). We have found that MR correlates
est with anterior leaflet length, not posterior length.
his discrepancy may be explained by a different study
opulation as the majority of our subjects had MR
97%) versus a minority of their patients (16%). Leaflet
nvolvement may also be a factor as information regard-
ng the percentages of bileaflet, anterior, or posterior
VP patients were not available in their study (30).
When considering only the bileaflet subjects,
nterior leaflet displacement was a significant de-
erminant of MR in univariate analysis. Among our
tudy subjects, there were no cases of anterior
eaflet–only prolapse. When all patients were con-
eaflet Length
-26 mm
<0.001
p=0.009
> 26 mm
0
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p=0.005
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) tertiles of anterior leaﬂet length, (B) posterior leaﬂet displace-
mm as the cutoff. Student t test was used to assess signiﬁcantTable 4. Intraobse
CMR Parameters
MAD (3-chamber)
AD
AL
AT
PD
PL
PT
PMC
PMA
PMP
Values are mean  SDor L
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1043ot impact severity of MR, which is likely because
he coaptation tends to be symmetric in bileaflet
rolapse, as opposed to isolated posterior or anterior
rolapse. The importance of posterior leaflet dis-
lacement in our analysis of determinants of MR
upports the recognized role of leaflet coaptation
symmetry in the mechanism of MR (30–32).
Leaflet thickness, an echocardiographic valvular
arameter associated with MR and MR-related
rognosis in MVP patients (8,26), was relevant in
he univariate, but not in the overall stepwise
egression model. However, when the analysis was
estricted to valvular characteristics only, posterior
eaflet thickness was a determinant in the regression
odel. When compared with normal, healthy con-
rol subjects, anterior leaflet thickness in MVP
atients was not significantly different, whereas
osterior leaflet thickness was greater (15). On
athological findings in formalin-fixed tissue, mean
ormal mitral leaflet thickness was 1 mm and mean
VP leaflet thickness was 2 mm (33). Partial
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Figure 3. Bland-Altman Graphs of Intraobserver and Interobser
(A and B) anterior leaﬂet length, (C and D) posterior displacement,
dotted lines denote mean  2 SD. Diff.  difference; MR  mitralolume averaging affects thickness measurements pecause routine CMR steady-state free-precession
maging has an in-plane spatial resolution of 2 mm.
MR anterior and posterior leaflet thicknesses were
reviously found to be on average 3.2 mm in 25
atients (15) and 2.8 mm on the current study in 71
atients. Subtle changes in leaflet thickness with
ncreased MR may have been undetectable due to
artial volume averaging. The presence of flail was
orrelated with increased regurgitant volume in uni-
ariate analysis and in the valvular regression analysis,
onsistent with previous reports (12,34) of flail as a
echanism for severe MR. Annular dimension was
ignificant in univariate regression and in 1 of the
tepwise regression model analyses, but was not re-
ained in the final overall model. LV mass was not
valuated in prior echocardiography studies, but had
ignificant contribution in our overall model as a very
trong predictor of MR (p  0.001 and R2  0.5),
eflecting the effects of chronic regurgitation on de-
elopment of compensatory hypertrophy.
It has been postulated that superior systolic dis-
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1044ension on the PM tips, causing their superior trac-
ion, and that such traction may have adverse patho-
hysiologic effects (35). The distance between the PM
ip and the mitral valve has been previously quantified
n MVP patients in an echocardiographic study (36),
ut correlation with MR was not studied. In our
tudy, we looked at the distance between the PM, the
oint of maximum leaflet displacement, and the mitral
alve coaptation point in relation to MR. The distance
etween the PM and the mitral valve coaptation point
as included in the analysis as it expresses the contri-
ution of 1 leaflet length relative to the other. The
M distance to valve leaflets and coaptation point
ere significant MR determinants in the univariate
ut not the stepwise overall model.
Despite its many advantages over echocardiogra-
hy, CMR is not as widely used, and clinical
xperience is relatively limited in assessing valvular
eart disease with, in particular, a lack of correlation
f CMR valvular parameters with clinical out-
omes. Therefore, finding valvular determinants of
VP-related MR is crucial for development of
rospective studies to define disease progression
nd the optimal timing of surgical intervention.
ur study showed acceptable intraobserver and
nterobserver variability with low percentage vari-
bility achievable in a trained observer, further
onfirming the ideal role of CMR as an imaging
odality for the assessment of MVP patients with
ignificant MR. To our knowledge, this is the first
tudy to fully investigate the reproducibility of
MR measurements for myxomatous valve disease.
tudy limitations. Several limitations exist in our
tudy. This is a cross-sectional study without lon-
itudinal follow-up. To fully understand the prog-
ostic role of CMR in patients with MVP,4. Devereux RB, Kramer-Fox R, Shear
MK, Kligfield P, Pini R, Savage DD. AJ. Echocardiogrogression of MR would be of particular interest.
ur sample size is small when all the variables of
he mitral apparatus are considered. To overcome
he overfitting issue when performing regression
nalysis for significant predictors, we limited the
alvular regression model input variables to valvular
haracteristics only and determined the final 4
redictors. Reassuringly, the strongest valvular pre-
ictors—anterior leaflet length and posterior leaflet
isplacement—were present in both the overall
odel and the valvular regression model. Our study
as laid the foundation for conducting a longitudi-
al study by assessing comprehensive CMR param-
ters of valvular and ventricular characteristics of
VP patients. An additional limitation is the lack
f anterior leaflet–only prolapse patients, which
ould be the result of excluding patients with more
han mild aortic regurgitation in our study design.
O N C L U S I O N S
n summary, anterior leaflet length, posterior leaflet
isplacement, posterior leaflet thickness, and the
resence of flail leaflet are the best CMR valvular
eterminants of MVP-related MR. Our findings
re reproducible and represent an important step
owards the development of prospective CMR
tudies to define MR progression.
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